A research collaboration exploring cognitive effects of caffeine and nootropics through integrated surveys, focus groups, social media analysis, and in silico molecular modeling. The team seeks to generate evidence-based insights into usage patterns, perceptions, and potential cognitive outcomes among university students and broader populations.
This research initiative investigates the cognitive effects of caffeine and nootropics using a mixed-methods approach that combines user surveys, focus groups, expert insights, social listening, and computational predictions. The goal is to produce a nuanced understanding of how cognitive enhancers are used, perceived, and experienced, generating evidence-based insights relevant to consumers, researchers, healthcare professionals, and policymakers.
The research group brings established expertise in cognitive enhancer studies and proficiency in social listening methodologies, enabling real-time capture of sentiments and trends among university student populations. Complementing this qualitative work, in silico prediction capabilities allow exploration of molecular interactions and identification of novel compounds with potential cognitive effects. Together, these methods offer a holistic perspective that bridges lived experience with computational analysis.
Research methodology:
Key capabilities:
The research approach is grounded in prior published work, including qualitative studies on cognitive enhancer perceptions, systematic reviews of university student use, and QSAR analyses demonstrating advanced computational methodology. The team has validated each component of the mixed-methods framework through these prior investigations. The next phase involves executing the integrated study, with planned publication and dissemination of findings. Future research directions will be identified to encourage ongoing discourse in the cognitive enhancement field.
Swansea University is a comprehensive public research university with dual campuses along Swansea Bay and a partnership-driven, applied research culture. Purpose-built facilities on the Bay Campus co-locate engineering research with company spaces and pilot-scale testbeds, accelerating product development and contract R&D. The Medical School works closely with NHS partners, with an adjacent hospital supporting clinical translation and real‑world evaluation. Research activity is backed by competitive national funding through UK Research and Innovation and Innovate UK, alongside NHS collaborations and Welsh Government support. A dedicated technology transfer office manages IP, licensing and spinout formation, with access to on‑campus collaboration and incubation space.